Summary
The work was based on the assumption that neurohumoral control of the immune response, particularly in stressed animals, involves central serotoninergic mechanisms. Rats immunized with sheep erythrocytes were stressed by repeated restraints and/or treated with a precursor of serotonin (5-hydroxytryptophan, 5-HTP) or with an inhibitor of serotonin synthesis (parachlorophenylalanine, PCPA). As expected, repeated stresses reduced the plaque-forming cell (PFC) response. Treatment with 5-HTP also reduced the PFC response, and potentiated the immunosuppressive effect of stress. This was accompanied by increased metabolism of serotonin in the brain, as indicated by increased concentration of its metabolite, 5-hydroxyindoleacetic acid (5-HIAA), in cerebral tissue. Treatment with PCPA also suppressed the PFC response, but this suppression was accompanied by decreased levels of brain serotonin and of 5-HIAA. Plasma corticosterone levels were elevated in rats treated with PCPA. It seems that putative central effects of PCPA on serotoninergic regulation of the immune response were outweighed by its effects on corticosterone secretion and/or on lymphoid cells.
This is a preview of subscription content, log in via an institution to check access.
References
Boranić, M., Peričić, D., Radačić, M., Poljak-Blaži, Šverko, V., and Miljenović, G., Biomed. Pharmacother.36 (1982) 23.
Devoino, L., Eliseeva, L., Eremina, O., Idova, G., and Cheido, M., Eur. J. Immun.5 (1975) 394.
Hall, N.R., and Goldstein, A.L., in: Psychoneuroimmunology, p. 52. Ed. R. Ader. Academic Press, New York 1981.
Pierpaoli, W., and Maestroni, G.J.M., Cell. Immun.31 (1977) 355.
Pierpaoli, W., and Maestroni, G.J.M., Immunology34 (1978) 419.
Pierpaoli, W., and Maestroni, G.J.M., J. Immun.120 (1978) 1600.
Vinnitsky, V.B., and Yakimenko, V.A., Vop. Onkol.27 (1981) 45.
Fuller, R.W., Snoddy, H.D., and Clemens, J.A., Endocr. Res. Commun.5 (1978) 161.
Fuller, R.W., and Snoddy, H.D., Neuroendocrinology31 (1980) 96.
Krieger, H.P., and Krieger, D.T., Am. J. Physiol.218 (1970) 1632.
Krieger, D.T., and Condon, E., J. clin. Endocr. Metab.46 (1978) 349.
Meyer, J.S., Buckholtz, N.S., and Boggan, W.O., Neuroendocrinology26 (1978) 312.
Jones, M.T., Birmingham, M., Gillham, B., Holmes, M., and Smith, T., Clin. Endocr.10 (1979) 203.
Berger, P.A., Barchas, J.D., and Vernikos-Daniellis, J., Nature248 (1974) 424.
Vermes, I., Telegdy, G., and Lissak, K., Acta physiol. hung.45 (1974) 217.
Vernikos-Danielis, J., Berger, P., and Barchas, J.D., in: Drug Effects on Neuroendocrine Regulation. Progress In Brain Research, p. 301. Eds E. Zimmermann, W.H. Gipsen, B.H. Marks and D. de Wied. Elsevier, Amsterdam 1973.
Rotsztejn, W.H., Beaudet, A., Roberge, A.G., Lalonde, J., and Fortier, C., Neuroendocrinology23 (1977) 157.
Ganong, W.F., in: Brain-Endocrine Interaction. Median Eminence: Structure and Function, p. 254. Eds K.M. Knigge and A. Weindl. Karger, Basel 1972.
Koe, B.K., and Weissman, A., J. Pharmac. exp. Ther.154 (1966) 499.
Welch, A.S., and Welch, B.L., Biochem. Pharmac.17 (1968) 699.
Peričić, D., Manev, H., Boranić, M., and Poljak-Blaži, M., Biomed. Pharmacother.36 (1982) 291.
Besedovsky, H.O., and Sorkin, E., in: Psychoneuroimmunology, p. 565. Ed. R. Ader. Academic Press, New York 1981.
Besedovsky, H., del Rey, A., Sorkin, E., Da Prada, M., Burri, R., and Honegger, C., Science221 (1983) 564.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boranić, M., Peričić, D., Poljak-Blaži, M. et al. Suppression of the immune response by drugs interfering with the metabolism of serotonin. Experientia 40, 1153–1155 (1984). https://doi.org/10.1007/BF01971469
Issue Date:
DOI: https://doi.org/10.1007/BF01971469